| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Approaches to seizure risk assessment in preclinical drug discovery
|
Easter, Alison
|
|
2009
|
14 |
17-18 |
p. 876-884
9 p.
|
artikel
|
| 2 |
Biotech acquisitions by big pharma: why and what is next
|
Malik, Nafees N.
|
|
2009
|
14 |
17-18 |
p. 818-821
4 p.
|
artikel
|
| 3 |
Contents page 2
|
|
|
2009
|
14 |
17-18 |
p. iii-
1 p.
|
artikel
|
| 4 |
Contents page 1
|
|
|
2009
|
14 |
17-18 |
p. i-
1 p.
|
artikel
|
| 5 |
Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study
|
Kooloos, Wouter M.
|
|
2009
|
14 |
17-18 |
p. 837-844
8 p.
|
artikel
|
| 6 |
Going to the dark side: success factors for companies leveraging senior academic talent
|
Yun, Joanne W.
|
|
2009
|
14 |
17-18 |
p. 815-817
3 p.
|
artikel
|
| 7 |
α7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?
|
Paleari, Laura
|
|
2009
|
14 |
17-18 |
p. 822-836
15 p.
|
artikel
|
| 8 |
‘OnePoint’ – combining OneNote and SharePoint to facilitate knowledge transfer
|
Barber, Christopher G.
|
|
2009
|
14 |
17-18 |
p. 845-850
6 p.
|
artikel
|
| 9 |
Orally bioavailable proteasome inhibitors: preclinical development of PR-047
|
Peese, Kevin
|
|
2009
|
14 |
17-18 |
p. 905-906
2 p.
|
artikel
|
| 10 |
Risk-based strategy for the assessment of pharmacokinetic drug–drug interactions for therapeutic monoclonal antibodies
|
Zhou, Honghui
|
|
2009
|
14 |
17-18 |
p. 891-898
8 p.
|
artikel
|
| 11 |
siRNAs: their potential as therapeutic agents – Part I. Designing of siRNAs
|
Hajeri, Praveensingh B.
|
|
2009
|
14 |
17-18 |
p. 851-858
8 p.
|
artikel
|
| 12 |
siRNAs: their potential as therapeutic agents – Part II. Methods of delivery
|
Singh, Sunit Kumar
|
|
2009
|
14 |
17-18 |
p. 859-865
7 p.
|
artikel
|
| 13 |
Synthetic drugs with anti-ageing effects
|
Kapoor, Vijay K.
|
|
2009
|
14 |
17-18 |
p. 899-904
6 p.
|
artikel
|
| 14 |
Targeting mitochondrial apoptosis by betulinic acid in human cancers
|
Fulda, Simone
|
|
2009
|
14 |
17-18 |
p. 885-890
6 p.
|
artikel
|
| 15 |
The complexity of the GABAA receptor shapes unique pharmacological profiles
|
D’Hulst, Charlotte
|
|
2009
|
14 |
17-18 |
p. 866-875
10 p.
|
artikel
|
Tijdschrift beschrijving